FinTrust Capital Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$46.4K Buy
644
+15
+2% +$1.06K 0.01% 588
2024
Q2
$43.3K Hold
629
0.01% 578
2024
Q1
$45.6K Hold
629
0.01% 548
2023
Q4
$38.5K Buy
629
+92
+17% +$5.46K 0.01% 563
2023
Q3
$30.7K Buy
537
+106
+25% +$6.41K 0.01% 561
2023
Q2
$27K Hold
431
0.01% 584
2023
Q1
$27K Hold
431
0.01% 582
2022
Q4
$27K Buy
431
+93
+28% +$5.33K 0.01% 581
2022
Q3
$18K Sell
338
-114
-25% -$6.31K ﹤0.01% 740
2022
Q2
$26K Buy
452
+76
+20% +$4.19K 0.01% 667
2022
Q1
$20K Buy
376
+87
+30% +$5.02K ﹤0.01% 767
2021
Q4
$18K Buy
+289
New +$17.2K ﹤0.01% 769

Other funds holding PBH

FinTrust Capital Advisors's PBH Position: Q3 2024 in Review

FinTrust Capital Advisors increased its Prestige Consumer Healthcare (PBH) stake by 2.4% in Q3 2024, buying an estimated $1.06K and bringing the position to 644 shares worth $46.4K. The position accounts for 0.01% of the portfolio, ranked #588.

FinTrust Capital Advisors first reported a position in PBH in Q4 2021 and has held it in 12 quarters since. 328 funds tracked by Wall St. Rank hold PBH as of Q3 2024.

  • FinTrust Capital Advisors held 644 shares of Prestige Consumer Healthcare worth $46.4K as of Q3 2024.
  • FinTrust Capital Advisors bought 15 Prestige Consumer Healthcare shares in Q3 2024, an estimated $1.06K.
  • Prestige Consumer Healthcare made up 0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #588 holding.
  • FinTrust Capital Advisors first reported a position in Prestige Consumer Healthcare in Q4 2021 and has held it in 12 quarters since.
  • 328 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.